問卷

TPIDB > Search Result > Clinical Trials List

Clinical Trials List

Protocol NumberTSHDM1101

2012-05-15 - 2014-04-14

Phase II

Terminated9

  • Trial Applicant

    TSH BIOPHARM CORPORATION LTD.

  • Sponsor

  • Trial scale

    Taiwan Multiple Center

  • Update

    2025/08/20

Investigators and Locations

Principal Investigator

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator 殷偉賢 Division of Cardiovascular Diseases

Co-Principal Investigator

  • 任勗龍 Division of Cardiovascular Diseases
  • 黃建龍 Division of Cardiovascular Diseases
  • 黃文彬 Division of Cardiovascular Diseases
  • 陳冠群 Division of Cardiovascular Diseases

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator 鄭書孟 Division of Cardiovascular Diseases

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator Hung-I Yeh Division of Cardiovascular Diseases

Co-Principal Investigator

  • 郭任遠 Division of Cardiovascular Diseases
  • 蘇正煌 Division of Cardiovascular Diseases
  • 陳正熙 Division of Cardiovascular Diseases
  • 吳懿哲 Division of Cardiovascular Diseases
  • 祁伯慶 Division of Cardiovascular Diseases
  • 洪大川 Division of Cardiovascular Diseases

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator Ming-Shien Wen Division of Cardiovascular Diseases

Co-Principal Investigator

  • 陳俊吉 Division of Cardiovascular Diseases
  • 洪國竣 Division of Cardiovascular Diseases
  • 王朝永 Division of Cardiovascular Diseases
  • 張尚宏 Division of Cardiovascular Diseases

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator 曾維功 Division of Cardiovascular Diseases

Co-Principal Investigator

  • 許寬立 Division of Cardiovascular Diseases
  • 李統立 Division of Cardiovascular Diseases
  • 施振祥 Division of Cardiovascular Diseases
  • 宣錦鋒 Division of Cardiovascular Diseases
  • 潘亞峰 Division of Cardiovascular Diseases

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator Kuo-Yang Wang Division of Cardiovascular Diseases

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator Hung-I Yeh Division of Cardiovascular Diseases

Co-Principal Investigator

  • 郭任遠 Division of Cardiovascular Diseases
  • 蘇正煌 Division of Cardiovascular Diseases
  • 陳正熙 Division of Cardiovascular Diseases
  • 吳懿哲 Division of Cardiovascular Diseases
  • 祁伯慶 Division of Cardiovascular Diseases
  • 洪大川 Division of Cardiovascular Diseases

The Actual Total Number of Participants Enrolled

0 Terminated

Condition/Disease

Objectives

Test Drug

Active Ingredient

Dosage Form

Dosage

Endpoints

Inclution Criteria

The Estimated Number of Participants

  • Taiwan

    95 participants

  • Global

    95 participants